HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
9.87 USD
+0.27 (+2.81%)
9.87 USD
0 (0%)
Taking everything into account, HLN scores 5 out of 10 in our fundamental rating. HLN was compared to 192 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are some minor concerns on its financial health. HLN is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HLN was profitable.
In the past year HLN had a positive cash flow from operations.
HLN had positive earnings in each of the past 5 years.
HLN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HLN's Return On Assets of 4.20% is amongst the best of the industry. HLN outperforms 85.42% of its industry peers.
Looking at the Return On Equity, with a value of 8.92%, HLN belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
With an excellent Return On Invested Capital value of 6.11%, HLN belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 13.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
The Profit Margin of HLN (12.84%) is better than 85.42% of its industry peers.
HLN's Profit Margin has improved in the last couple of years.
HLN has a better Operating Margin (21.31%) than 88.54% of its industry peers.
HLN's Operating Margin has improved in the last couple of years.
The Gross Margin of HLN (60.75%) is better than 69.79% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HLN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HLN has been reduced compared to 5 years ago.
HLN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.32 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLN has a Altman-Z score of 2.32. This is in the better half of the industry: HLN outperforms 65.63% of its industry peers.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 5.11, HLN belongs to the best of the industry, outperforming 81.77% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
The Debt to Equity ratio of HLN (0.53) is worse than 63.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.74
WACC8.27%
2.3 Liquidity
HLN has a Current Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN has a Current ratio of 0.98. This is amonst the worse of the industry: HLN underperforms 82.81% of its industry peers.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. HLN is outperformed by 84.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
The Revenue has decreased by -0.61% in the past year.
The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
Based on estimates for the next years, HLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.93% on average per year.
Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.64% on average per year.
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y9.93%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.56, HLN is valued on the expensive side.
80.21% of the companies in the same industry are more expensive than HLN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.45, HLN is valued at the same level.
With a Price/Forward Earnings ratio of 17.60, HLN is valued on the expensive side.
Based on the Price/Forward Earnings ratio, HLN is valued a bit cheaper than the industry average as 78.65% of the companies are valued more expensively.
HLN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.56 | ||
| Fwd PE | 17.6 |
4.2 Price Multiples
HLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HLN is cheaper than 81.25% of the companies in the same industry.
HLN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HLN is cheaper than 84.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.94 | ||
| EV/EBITDA | 15.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.8
PEG (5Y)1.17
EPS Next 2Y7.76%
EPS Next 3Y8.62%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.84%, HLN has a reasonable but not impressive dividend return.
HLN's Dividend Yield is rather good when compared to the industry average which is at 7.87. HLN pays more dividend than 92.71% of the companies in the same industry.
HLN's Dividend Yield is slightly below the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of HLN decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
9.87
+0.27 (+2.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap43.95B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts80
Price Target11.2 (13.48%)
Short Float %0.2%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.63%
PT rev (3m)-3.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)0.17%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.56 | ||
| Fwd PE | 17.6 | ||
| P/S | 2.99 | ||
| P/FCF | 16.94 | ||
| P/OCF | 14.6 | ||
| P/B | 2.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.25 |
EPS(TTM)0.48
EY4.86%
EPS(NY)0.56
Fwd EY5.68%
FCF(TTM)0.58
FCFY5.9%
OCF(TTM)0.68
OCFY6.85%
SpS3.3
BVpS4.75
TBVpS-2.95
PEG (NY)3.8
PEG (5Y)1.17
Graham Number7.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.32 |
F-Score6
WACC8.27%
ROIC/WACC0.74
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y9.93%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.64%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.25%
EBIT Next 5Y7.7%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 5 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.56 and the Price/Book (PB) ratio is 2.08.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 4 / 10.